CAS: 150821-03-7 - N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide hemihydrate
Formula:C54H48N10O9
InChI:InChI=1/2C27H23N5O4.H2O/c2*33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18;/h2*1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32);1H2
- Synonyms:
- Pranlukast hydrate
- Ono-1070(monoNa salt)
- Sb-205312
- Rs-411
- Ono-RS-411
- Ono-1078
- Ultair
- Onon
- N-[4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide hydrate (2:1)
- Pranlukast Hemihydrate
- See more synonyms
Pranlukast hydrate
CAS:150821-03-7
Formula:
C27H23N5O4·xH2O
Purity:
(HPLC) ≥ 99.0%
Color and Shape:
White powder or crystals
Molecular weight:
481.50 (anhydrous)
Ref: 7W-GP8160
25mg | 60.00 € | |
50mg | 101.00 € | |
250mg | 229.00 € |
Estimated delivery in United States, on Friday 3 May 2024
Ref: 2K-1129400021
100mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
Pranlukast Hemihydrate
CAS:150821-03-7
Formula:
C54H48N10O9
Color and Shape:
White to Pale Yellow Solid
Molecular weight:
981.05
Ref: TR-P032425
10mg | 160.00 € | |
50mg | 260.00 € | |
100mg | 407.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Pranlukast hemihydrate
CAS:150821-03-7
Pranlukast is a leukotriene receptor antagonist that is used to treat asthma and other inflammatory …
Formula:
C27H23N5O4·5H2O
Purity:
Min. 95%
Molecular weight:
490.51 g/mol
Ref: 3D-AGA82103
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Thursday 13 Jun 2024